PROTAC TTK degrader-2

Catalog No. :
ACERYO614
CAS No. :
2953426-48-5
Molecular Formula :
C49H57N9O7
Molecular Weight :
884.05

IUPAC Name:N-(4-(2-((4-(4-(8-(2-(2,6-dioxopiperidin-3-yl)-3-oxoisoindolin-5-yl)oct-7-ynoyl)piperazin-1-yl)-2-methoxyphenyl)amino)-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8(7H)-yl)cyclohexyl)propionamide

PROTAC TTK degrader-2 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePROTAC TTK degrader-2
IUPAC NameN-(4-(2-((4-(4-(8-(2-(2,6-dioxopiperidin-3-yl)-3-oxoisoindolin-5-yl)oct-7-ynoyl)piperazin-1-yl)-2-methoxyphenyl)amino)-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8(7H)-yl)cyclohexyl)propionamide
Molecular FormulaC49H57N9O7
Molecular Weight884.05
SMILESCCC(NC1CCC(N(C2=NC(NC3=CC=C(N4CCN(C(CCCCCC#CC5=CC6=C(CN(C(CC7)C(NC7=O)=O)C6=O)C=C5)=O)CC4)C=C3OC)=NC=C2C(C)=C8)C8=O)CC1)=O
InChI KeyXWOZFCIASHOPCP-UHFFFAOYSA-N
SynonymPROTAC TTK degrader-2;Propanamide, N-[cis-4-[2-[[4-[4-[8-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-3-oxo-1H-isoindol-5-yl]-1-oxo-7-octyn-1-yl]-1-piperazinyl]-2-methoxyphenyl]amino]-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8(7H)-yl]cyclohexyl]-
CAS No.2953426-48-5

Synthetic Route by SureRoute

1. ACERYO614 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFDHL658 route compound structure diagram
    ACFDHL6582304513-76-4 In Stock
  4. Then
  5. ACERYO614 route product structure diagram
    ACERYO6142953426-48-5
Inquiry

2. ACERYO614 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFDHL658 route compound structure diagram
    ACFDHL6582304513-76-4 In Stock
  4. Then
  5. ACERYO614 route product structure diagram
    ACERYO6142953426-48-5
Inquiry

Comments (0)